Delivery Order SPE2DR25D2100-SPE2DR26FA0VW
Award Date 12/29/25
Potential Completion Date 12/30/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,013.55 for Naropin 0.5% (150 mg/30 mL vial) with an ultimate completion date of October 16, 2025. This firm fixed price, non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,105.45 to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Naropin 1% (200 mg/20 mL vials). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,627.60 and is for the delivery of the drug NAROPIN 0.5% 100 MG/20 ML VIAL 20ML. The contract is a firm-fixed price, delivery order type and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Naropin 0.5% 150 mg/30 ml vials to the Defense Logistics Agency (DLA), a defense agency. The $2,331.68 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 13, 2024, with a completion date of December 16, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,099.88 firm fixed-price contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, with a completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.42, is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. This award...
- The Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEKV1, valued at $2,638.47, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This firm fixed price delivery order is for the supply of 4564230198 NAROPIN 0.5% 150 MG/30 ML VIAL 30ML to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp, which has a potential value of...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRBJ7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,523.20 delivery order is for the supply of the pharmaceutical product NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract has a firm fixed price and an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,274.68 firm fixed price delivery order is for the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563539837 NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $5,221.35. The contract is a firm fixed-price delivery order that runs through February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs)...